The study aims to describe alterations in the contact activation system during active and inactive ulcerative colitis. Contact activation system measures are compared in a cross sectional (healthy controls vs. active disease) and longitudinal (active diasese vs. inactive disease) fashion.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Clinical disease activity.
Timeframe: End of study (August 28th, 2024)
Endoscopic disease activity.
Timeframe: End of study (August 28th, 2024)
Kallikrein generation
Timeframe: End of study (August 28th, 2024)
Polymerised alpha-1-antitrypsin in participants
Timeframe: End of study (August 28th, 2024)
Polymerised alpha-1-antitrypsin as an activator of the contact activation system
Timeframe: End of study (August 28th, 2024)
Localisation of contact activation system components in tissue samples
Timeframe: End of study (August 28th, 2024)